Ascentage Pharma Group International (06855)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Chan Charmayne | 25-Feb-25 | CoSec | |||
| Lippman Marc E | 02-Jan-25 | INED | |||
| Bozilenko Marina S | 25-Nov-24 | INED | |||
| Yu Debra Jiuyun | 25-Nov-24 | INED | |||
| Sidransky David | 31-Mar-21 | INED | |||
| Zhu Gang | 01-Oct-20 | Sen Mgr | |||
| Ren Wei | 13-Jun-19 | INED | |||
| Ye Benjamin Changqing | 13-Jun-19 | INED | |||
| Kmetz Raymond Jeffrey | 01-Feb-19 | Sen Mgr | |||
| Lu Simon Dazhong | 06-Jul-18 | NED | |||
| Wang Shaomeng | 17-Nov-17 | NED | |||
| Yang Dajun | 17-Nov-17 | Ch, CEO, Co-Fdr | |||
| Zhai Yifan | 16-Jul-13 | Sen Mgr | |||
| Wong Johnny Cheung Ki | 30-Jul-18 | 25-Feb-25 | CoSec | ||
| Yin Zheng | 13-Jun-19 | 07-Jun-24 | INED | ||
| Chen Yiqing | 29-Nov-21 | 16-Nov-22 | CFO | ||
| Liu Qian | 01-Aug-18 | 20-May-22 | NED | ||
| Tian Yuan | 06-Jul-18 | 20-May-22 | NED | ||
| Zhang Su | 26-Aug-19 | 01-Nov-21 | CFO | ||
| Guo Edward Ming | 16-May-09 | 31-Oct-21 | COO | ||
| Zhao Qun | 06-Jul-18 | 31-Mar-21 | NED |